SYSTEMIC INTERLEUKIN 1β INHIBITION IN PROLIFERATIVE DIABETIC RETINOPATHY: A Prospective Open-Label Study Using Canakinumab.

Retina · 2016 · PMC4747976 · PMID 26218500

Europe PMC DOI

hedged sentence

0.7790

closest p · 15.6× alpha

0.7790

boldest claim

The sentences

did not reach statistical significanceP = 0.779not close (p > 0.1)

At Weeks 8 and 16, NVE size was reduced to 0.50 mm 2 and 0.36 mm 2 , respectively but did not reach statistical significance compared with baseline ( P = 0.779 and P = 0.123, respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.